ConductScience.org, home

Paper40959486

Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models.

Stelse-Masson S and 15 others. Nanotheranostics, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models. Papers, record 40959486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40959486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models.
PubMed
Journal
Nanotheranostics
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-07-07
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stelse-Masson SSarah
2Lytvynenko XXenie
3Bedregal-Portugal KKristel
4Aubrun CClémentine
5Lavaud MMatéo
6Kadri MMalika
7Jacquet TThibault
8Moriscot CChristine
9Gallet BBenoit
10Chovelon BBenoit
11Coll JLJean-Luc
12Ravanat JLJean-Luc
13Mihóková EEva
14Čuba VVáclav
15Elleaume HHélène
16Bulin ALAnne-Laure

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
LutetiumMajor topic
NanoparticlesMajor topic
Radiation-Sensitizing AgentsMajor topic
Humans
Cell Line, Tumor
Silicon Dioxide
Monte Carlo Method

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18956786Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside.Br J Cancer1996https://conductscience.org/library/papers/8956786PubMed
235097226NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.Clin Transl Radiat Oncol2022https://conductscience.org/library/papers/35097226PubMed
329192263Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.Sci Rep2017https://conductscience.org/library/papers/29192263PubMed
430589178CT/MRI-Guided Synergistic Radiotherapy and X-ray Inducible Photodynamic Therapy Using Tb-Doped Gd-W-Nanoscintillators.Angew Chem Int Ed Engl2019https://conductscience.org/library/papers/30589178PubMed
53562895Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors.Radiother Oncol1987https://conductscience.org/library/papers/3562895PubMed
627939934Radiation-induced clustered DNA lesions: Repair and mutagenesis.Free Radic Biol Med2017https://conductscience.org/library/papers/27939934PubMed
735850363
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
Int J Radiat Oncol Biol Phys2022https://conductscience.org/library/papers/35850363PubMed
821617154Photodynamic therapy of cancer: an update.CA Cancer J Clin2011https://conductscience.org/library/papers/21617154PubMed
927877247Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.Theranostics2016https://conductscience.org/library/papers/27877247PubMed
1030156333Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization.Adv Mater2019https://conductscience.org/library/papers/30156333PubMed
1140213580Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models.Small Sci2024https://conductscience.org/library/papers/40213580PubMed
1230523903The linear quadratic model: usage, interpretation and challenges.Phys Med Biol2018https://conductscience.org/library/papers/30523903PubMed
1317877427Characterization of the theorectical radiation dose enhancement from nanoparticles.Technol Cancer Res Treat2007https://conductscience.org/library/papers/17877427PubMed
1424569464Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.Br J Cancer2014https://conductscience.org/library/papers/24569464PubMed
1525746211Modelling energy deposition in nanoscintillators to predict the efficiency of the X-ray-induced photodynamic effect.Nanoscale2015https://conductscience.org/library/papers/25746211PubMed
1632684987Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?Ther Adv Med Oncol2020https://conductscience.org/library/papers/32684987PubMed
1715509078The use of gold nanoparticles to enhance radiotherapy in mice.Phys Med Biol2004https://conductscience.org/library/papers/15509078PubMed
1829413988LuAG:Pr3+-porphyrin based nanohybrid system for singlet oxygen production: Toward the next generation of PDTX drugs.J Photochem Photobiol B2018https://conductscience.org/library/papers/29413988PubMed
1935020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
2035205732Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment.Cancers (Basel)2022https://conductscience.org/library/papers/35205732PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
42550387Landscape and evolutionary trends of nanotechnology in cancer radiosensitization.Discov Nano2026https://conductscience.org/library/papers/42550387

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40959486

GET https://conductscience.org/api/papers/v1/40959486/references?page=2